HEXATRIONE 2%- triamcinolone hexacetonide injection, suspension 
Medexus Pharma, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Hexatrione

DHCP_01DHCP_02DHCP_03DHCP_04DHCP_05DHCP_06DHCP_07DHCP_08DHCP_09DHCP_10DHCP_11DHCP_12DHCP_13DHCP_14DHCP_15DHCP_16DHCP_17DHCP_18DHCP_19DHCP_20DHCP_21DHCP_22DHCP_23DHCP_24DHCP_25DHCP_26

NDC 59137-570-01

20 mg/mL (2 mL Ampoule) - Ampoule Label

Ampoule Label

20 mg/mL (2 mL Ampoule) - Carton Label

Carton

HEXATRIONE  2%
triamcinolone hexacetonide injection, suspension
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:59137-570
Route of AdministrationINTRA-ARTICULAR
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TRIAMCINOLONE HEXACETONIDE (UNII: I7GT1U99Y9) (TRIAMCINOLONE ACETONIDE - UNII:F446C597KA) TRIAMCINOLONE HEXACETONIDE40 mg  in 2 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
SORBITOL SOLUTION 70% (UNII: 8KW3E207O2)  
WATER (UNII: 059QF0KO0R)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:59137-570-011 in 1 CARTON03/03/2021
12 mL in 1 AMPULE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug for use in drug shortage03/03/2021
Labeler - Medexus Pharma, Inc. (078811131)
Establishment
NameAddressID/FEIBusiness Operations
Valdepharm260128560manufacture(59137-570)

Revised: 12/2021
Document Id: d2a6241f-8ed9-6f53-e053-2995a90ac73a
Set id: bc07ae9f-8a74-6bc8-e053-2995a90afc0d
Version: 2
Effective Time: 20211208
 
Medexus Pharma, Inc.